TrueMark Investments LLC Purchases 16,567 Shares of UnitedHealth Group Incorporated $UNH

TrueMark Investments LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 128.0% during the second quarter, according to its most recent filing with the SEC. The firm owned 29,515 shares of the healthcare conglomerate’s stock after purchasing an additional 16,567 shares during the period. UnitedHealth Group accounts for approximately 2.0% of TrueMark Investments LLC’s portfolio, making the stock its 6th largest position. TrueMark Investments LLC’s holdings in UnitedHealth Group were worth $9,208,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of the business. Vanguard Group Inc. raised its holdings in UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after buying an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP grew its position in UnitedHealth Group by 10.6% during the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after buying an additional 2,486,839 shares during the period. Bank of New York Mellon Corp grew its position in UnitedHealth Group by 2.5% during the first quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate’s stock valued at $4,257,131,000 after buying an additional 196,696 shares during the period. Nuveen LLC bought a new position in UnitedHealth Group during the first quarter valued at about $3,846,764,000. Finally, Charles Schwab Investment Management Inc. grew its position in UnitedHealth Group by 13.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock valued at $3,702,736,000 after buying an additional 847,054 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Wells Fargo & Company increased their price target on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research report on Tuesday, October 7th. Oppenheimer cut their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. UBS Group reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. JPMorgan Chase & Co. increased their target price on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Eighteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $385.13.

UnitedHealth Group Price Performance

UNH stock opened at $356.53 on Friday. The firm has a 50 day moving average of $329.38 and a 200-day moving average of $343.62. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The firm has a market capitalization of $322.90 billion, a P/E ratio of 15.45, a price-to-earnings-growth ratio of 2.31 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group’s revenue was up 12.9% compared to the same quarter last year. During the same quarter last year, the business posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.